206 related articles for article (PubMed ID: 32496823)
1. What place does molecular topology have in today's drug discovery?
Zanni R; Galvez-Llompart M; Garcia-Domenech R; Galvez J
Expert Opin Drug Discov; 2020 Oct; 15(10):1133-1144. PubMed ID: 32496823
[TBL] [Abstract][Full Text] [Related]
2. Latest advances in molecular topology applications for drug discovery.
Zanni R; Galvez-Llompart M; García-Domenech R; Galvez J
Expert Opin Drug Discov; 2015; 10(9):945-57. PubMed ID: 26134383
[TBL] [Abstract][Full Text] [Related]
3. Molecular topology as a novel approach for drug discovery.
Gálvez J; Gálvez-Llompart M; García-Domenech R
Expert Opin Drug Discov; 2012 Feb; 7(2):133-53. PubMed ID: 22468915
[TBL] [Abstract][Full Text] [Related]
4. The application of molecular topology for ulcerative colitis drug discovery.
Bellera CL; Di Ianni ME; Talevi A
Expert Opin Drug Discov; 2018 Jan; 13(1):89-101. PubMed ID: 29088918
[TBL] [Abstract][Full Text] [Related]
5. On the contribution of molecular topology to drug design and discovery.
Gálvez J; García-Doménech R
Curr Comput Aided Drug Des; 2010 Dec; 6(4):252-68. PubMed ID: 20883200
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
Wang T; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
[TBL] [Abstract][Full Text] [Related]
7. 4D- quantitative structure-activity relationship modeling: making a comeback.
Fourches D; Ash J
Expert Opin Drug Discov; 2019 Dec; 14(12):1227-1235. PubMed ID: 31513441
[No Abstract] [Full Text] [Related]
8. The advancement of multidimensional QSAR for novel drug discovery - where are we headed?
Wang T; Yuan XS; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2017 Aug; 12(8):769-784. PubMed ID: 28562095
[TBL] [Abstract][Full Text] [Related]
9. Have artificial neural networks met expectations in drug discovery as implemented in QSAR framework?
Dobchev D; Karelson M
Expert Opin Drug Discov; 2016 Jul; 11(7):627-39. PubMed ID: 27149299
[TBL] [Abstract][Full Text] [Related]
10. Advances in the molecular modeling and quantitative structure-activity relationship-based design for antihistamines.
Galvez J; Galvez-Llompart M; Zanni R; Garcia-Domenech R
Expert Opin Drug Discov; 2013 Mar; 8(3):305-17. PubMed ID: 23289365
[TBL] [Abstract][Full Text] [Related]
11. QSAR studies in the discovery of novel type-II diabetic therapies.
Abuhammad A; Taha MO
Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
[TBL] [Abstract][Full Text] [Related]
12. Multitasking models for quantitative structure-biological effect relationships: current status and future perspectives to speed up drug discovery.
Speck-Planche A; Cordeiro MN
Expert Opin Drug Discov; 2015 Mar; 10(3):245-56. PubMed ID: 25613725
[TBL] [Abstract][Full Text] [Related]
13. Application of SMILES Notation Based Optimal Descriptors in Drug Discovery and Design.
Veselinović AM; Veselinović JB; Živković JV; Nikolić GM
Curr Top Med Chem; 2015; 15(18):1768-79. PubMed ID: 25961525
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical Significance of Topological Indices: Importance in Drug Discovery Research.
Bhatia KS; Gupta AK; Saxena AK
Curr Top Med Chem; 2023; 23(29):2735-2742. PubMed ID: 37519204
[TBL] [Abstract][Full Text] [Related]
15. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional molecular descriptors and a novel QSAR method.
Wildman SA; Crippen GM
J Mol Graph Model; 2002 Dec; 21(3):161-70. PubMed ID: 12463634
[TBL] [Abstract][Full Text] [Related]
17. An overview of neural networks for drug discovery and the inputs used.
Xu Y; Yao H; Lin K
Expert Opin Drug Discov; 2018 Dec; 13(12):1091-1102. PubMed ID: 30449189
[No Abstract] [Full Text] [Related]
18. Development of quantitative structure-activity relationships and its application in rational drug design.
Yang GF; Huang X
Curr Pharm Des; 2006; 12(35):4601-11. PubMed ID: 17168765
[TBL] [Abstract][Full Text] [Related]
19. Challenges with multi-objective QSAR in drug discovery.
Lambrinidis G; Tsantili-Kakoulidou A
Expert Opin Drug Discov; 2018 Sep; 13(9):851-859. PubMed ID: 29996683
[TBL] [Abstract][Full Text] [Related]
20. QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.
Garro Martinez JC; Vega-Hissi EG; Andrada MF; Estrada MR
Expert Opin Drug Discov; 2015 Jan; 10(1):37-51. PubMed ID: 25297377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
